Surgery Partners, Inc.
23.225USD
+7.4750 (+47.46%)
Fetching financial statements from SEC filings…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on SGRY.
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 849 | 811 | 885 | 822 | 826 | 776 | 864 | 770 |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Operating Income | 102 | 66 | 110 | 106 | 112 | 62 | 127 | 61 |
| Net Income | -15 | -36 | -15 | -23 | -3 | -38 | -109 | -32 |
| EPS (Diluted) | -$0.12 | -$0.28 | -$0.11 | -$0.18 | -$0.02 | -$0.30 | -$0.86 | -$0.25 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)